Clinical Trial Update: Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial exploring whether protocolized magnesium replacement affects mortality and atrial fibrillation in critically ill patients is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Snippet

Sponsor: Scarborough General Hospital | Conditions: Critical Illness | Phase 4 | Status: RECRUITING